Israeli Botanical Company Releases Skin Remedies in US

Clinically Proven Plant-Based Treatments for Eczema, Acne & Dandruff, Now Available in the U.S.

Pharmaceutical companies today are making major investments in plant-derived drugs, with the global market expected to hit nearly $40 billion by 2022 and the largest growth coming in the botanical sector, according to a just-released research report.  But Israeli-based Kamedis has beaten them to market with a line of over-the-counter products that use ancient Chinese medicine to heal problem skin – inspired by the CEO, Roni Kramer, who holds a degree in traditional Chinese medicine and Chinese herbology.

We use cookies to improve your experience on our website. Read about how we use cookies in our Privacy Policy. By browsing this website, you agree to our use of cookies.

You have successfully subscribed!